Literature DB >> 12042196

Attention deficit hyperactivity disorder and the gene for dopamine Beta-hydroxylase.

Karen Wigg1, Gwyneth Zai, Russell Schachar, Rosemary Tannock, Wendy Roberts, Molly Malone, James L Kennedy, Cathy L Barr.   

Abstract

OBJECTIVE: Attention deficit hyperactivity disorder (ADHD) has been shown to be highly heritable, and recent molecular genetics studies have focused on candidate genes in the dopaminergic and noradrenergic systems. One recent study reported an association of an allele of the TaqI polymorphism located in the fifth intron of the gene for dopamine beta-hydroxylase (DBH). The authors' goal was to replicate this finding.
METHOD: The authors investigated the linkage of the alleles and haplotypes of three polymorphisms at the DBH locus in 117 nuclear families with ADHD.
RESULTS: No significant evidence was found for linkage of the TaqI alleles or haplotypes in the 117 families. However, the authors observed some evidence for biased transmission of the same allele of the TaqI polymorphism, as previously reported.
CONCLUSIONS: These findings suggest that the gene for DBH should be investigated further.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042196     DOI: 10.1176/appi.ajp.159.6.1046

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  11 in total

1.  A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q.

Authors:  S C Bakker; E M van der Meulen; J K Buitelaar; L A Sandkuijl; D L Pauls; A J Monsuur; R van 't Slot; R B Minderaa; W B Gunning; P L Pearson; R J Sinke
Journal:  Am J Hum Genet       Date:  2003-04-04       Impact factor: 11.025

2.  Brief report: pervasive developmental disorder can evolve into ADHD: case illustrations.

Authors:  Deborah Fein; Pamela Dixon; Jennifer Paul; Harriet Levin
Journal:  J Autism Dev Disord       Date:  2005-08

Review 3.  Molecular genetics of attention deficit hyperactivity disorder.

Authors:  Stephen V Faraone; Eric Mick
Journal:  Psychiatr Clin North Am       Date:  2010-03

4.  An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood.

Authors:  Russell A Barkley; Karen M Smith; Mariellen Fischer; Bradford Navia
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-07-05       Impact factor: 3.568

Review 5.  Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.

Authors:  J F Cubells; C P Zabetian
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

Review 6.  Genetic aspects in attention-deficit/hyperactivity disorder.

Authors:  O Albayrak; S Friedel; B G Schimmelmann; A Hinney; J Hebebrand
Journal:  J Neural Transm (Vienna)       Date:  2008-01-16       Impact factor: 3.575

7.  Study on DBH genetic polymorphisms and plasma activity in attention deficit hyperactivity disorder patients from Eastern India.

Authors:  Nipa Bhaduri; Kanyakumarika Sarkar; Swagata Sinha; Anindita Chattopadhyay; Kanchan Mukhopadhyay
Journal:  Cell Mol Neurobiol       Date:  2009-09-16       Impact factor: 5.046

Review 8.  Candidate gene studies of ADHD: a meta-analytic review.

Authors:  Ian R Gizer; Courtney Ficks; Irwin D Waldman
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

9.  Developmental Changes of Catecholamine-mediating Enzyme - Dopamine-β- Hydroxylase and Its Cofactors in Central and Peripheral Tissues and Serum of Long-Evans Rats.

Authors:  M Khalilur Rahman; M Iqbal Choudhary; M Rafiqul Islam; Rahman M Hafizur
Journal:  Int J Biomed Sci       Date:  2012-09

10.  Novel repeat polymorphisms of the dopaminergic neurotransmitter genes among dogs and wolves.

Authors:  Krisztina Hejjas; Judit Vas; Eniko Kubinyi; Maria Sasvari-Szekely; Adam Miklosi; Zsolt Ronai
Journal:  Mamm Genome       Date:  2007-11-30       Impact factor: 3.224

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.